Trevi Therapeutics, Inc. Common Stock
TRVI •
Buy Open
Signal type
Buy
Status
Open
Open Price
$13.30
Stop Loss
$12.58
Performance
5.56%
Days Open
8
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 7, 2026
Open Price $13.30
Stop Loss $12.58
Timespan Day
Company Profile
Name Trevi Therapeutics, Inc. Common Stock
Ticker TRVI
Market Cap $666.00M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $14.04
List Date May 3, 2019
Description
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
Website Open Company Website